Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02863029 · ClinicalTrials.gov registry record · NA
Defining the Role of the Gut Microbiome in Mediating the Effects of Obesity on Intestinal Stem Cells
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02863029: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT02863029 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02863029, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
New studies are revealing how a high-fat diet could be making the cells of the intestinal lining more likely to become cancerous. The investigators would like to study how obesity influences growth of intestinal stem cells, which could then trigger intestinal tumors. The investigators are proposing a Pilot Study of 20 subjects (comprised of 10 participants from each of two different BMI categories: 20-25 and 35 \& above), who will be asked to provide blood, stool, \& urine samples, undergo a flexible sigmoidoscopy, and complete food frequency questionnaires
Interventions
- PROCEDURE Flexible Sigmoidoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2017-01 |
| Est. Completion | 2017-03-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02863029
The ClinicalTrials.gov registry entry for NCT02863029 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Flexible Sigmoidoscopy is the first listed.
NCT02863029 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02863029 about?
NCT02863029 is a clinical study titled "Defining the Role of the Gut Microbiome in Mediating the Effects of Obesity on Intestinal Stem Cells". New studies are revealing how a high-fat diet could be making the cells of the intestinal lining more likely to become cancerous. The investigators would like to study how obesity influences growth of intestinal stem cells, which could then trigger intestinal tumors. The investigators are proposing...
What is the current status of trial NCT02863029?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2017-01. Estimated completion is 2017-03-09.
What interventions are being tested in trial NCT02863029?
The interventions under investigation include: Flexible Sigmoidoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT02863029?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.